Glaucoma Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Glaucoma stocks.

Glaucoma Stocks Recent News

Date Stock Title
May 17 IRIX IRIDEX Corporation (IRIX) Q1 2024 Earnings Call Transcript
May 15 ALC Oppenheimer raises Alcon to outperform, cites multiple drivers
May 15 ACAD Acadia Pharmaceuticals Announces Launch of Magnolia's Guide to Adventuring: A Groundbreaking Documentary Series Aiming to Raise Disease Awareness and Redefine Perceptions of Rett Syndrome
May 15 ALC Alcon Analysts Increase Their Forecasts Following Q1 Results
May 15 IRIX Q1 2024 IRIDEX Corp Earnings Call
May 15 IRIX IRIDEX Corp (IRIX) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with ...
May 14 IRIX Iridex (IRIX) Reports Q1 Loss, Misses Revenue Estimates
May 14 IRIX IRIDEX GAAP EPS of -$0.21 misses by $0.09, revenue of $11.8M misses by $0.2M
May 14 IRIX Iridex Reports First Quarter 2024 Financial Results
May 14 ALC Alcon (ALC) Q1 Earnings Surpass Estimates, Margins Expand
May 14 GKOS Glaukos (GKOS) Reaches 52-Week High: What's Aiding the Stock?
May 14 ALC Alcon Inc. (ALC) Q1 2024 Earnings Call Transcript
May 14 ALC Biggest stock movers today: Meme stocks, BABA, ALC, and more
May 14 ALC Health Care Roundup: Market Talk
May 14 ALC Alcon Q1: Robust Product Pipeline Drives Future Growth (Rating Upgrade)
May 14 LXRX New Post-Hoc Analysis of Pooled Phase 3 Data Shows That INPEFA® (Sotagliflozin) Reduced Risk of Heart Failure Events in Patients With Preserved Ejection Fraction
May 14 IRIX Even after rising 11% this past week, IRIDEX (NASDAQ:IRIX) shareholders are still down 59% over the past three years
May 13 ALC Compared to Estimates, Alcon (ALC) Q1 Earnings: A Look at Key Metrics
May 13 ALC 2 Intriguing Medical Stocks to Buy for Steady Growth as Earnings Approach
May 13 ALC Alcon Non-GAAP EPS of $0.78 beats by $0.05, revenue of $2.44B misses by $30M
Glaucoma

Glaucoma is a group of eye diseases which result in damage to the optic nerve and vision loss. The most common type is open-angle glaucoma with less common types including closed-angle glaucoma and normal-tension glaucoma. Open-angle glaucoma develops slowly over time and there is no pain. Peripheral vision may begin to decrease followed by central vision resulting in blindness if not treated. Closed-angle glaucoma can present gradually or suddenly. The sudden presentation may involve severe eye pain, blurred vision, mid-dilated pupil, redness of the eye, and nausea. Vision loss from glaucoma, once it has occurred, is permanent.Risk factors for glaucoma include increased pressure in the eye, a family history of the condition, and high blood pressure. For eye pressures a value of greater than 21 mmHg or 2.8 kPa is often used with higher pressures leading to a greater risk. However, some may have high eye pressure for years and never develop damage. Conversely, optic nerve damage may occur with normal pressure, known as normal-tension glaucoma. The mechanism of open-angle glaucoma is believed to be slow exit of aqueous humor through the trabecular meshwork while in closed-angle glaucoma the iris blocks the trabecular meshwork. Diagnosis is by a dilated eye examination. Often the optic nerve shows an abnormal amount of cupping.If treated early it is possible to slow or stop the progression of disease with medication, laser treatment, or surgery. The goal of these treatments is to decrease eye pressure. A number of different classes of glaucoma medication are available. Laser treatments may be effective in both open-angle and closed-angle glaucoma. A number of types of glaucoma surgeries may be used in people who do not respond sufficiently to other measures. Treatment of closed-angle glaucoma is a medical emergency.About 6 to 67 million people have glaucoma globally. The disease affects about 2 million people in the United States. It occurs more commonly among older people. Closed-angle glaucoma is more common in women. Glaucoma has been called the "silent thief of sight" because the loss of vision usually occurs slowly over a long period of time. Worldwide, glaucoma is the second-leading cause of blindness after cataracts. The word "glaucoma" is from Ancient Greek glaukos which means blue, green, or gray. In English, the word was used as early as 1587 but did not become commonly used until after 1850, when the development of the ophthalmoscope allowed people to see the optic nerve damage.

Browse All Tags